4.50
+0.11(+2.51%)
Currency In USD
| Previous Close | 4.39 |
| Open | 4.38 |
| Day High | 4.56 |
| Day Low | 4.32 |
| 52-Week High | 21.98 |
| 52-Week Low | 3.1 |
| Volume | 218,047 |
| Average Volume | 1.03M |
| Market Cap | 81.69M |
| PE | -0.39 |
| EPS | -11.56 |
| Moving Average 50 Days | 4.45 |
| Moving Average 200 Days | 12.39 |
| Change | 0.11 |
If you invested $1000 in Outset Medical, Inc. (OM) since IPO date, it would be worth $4.94 as of February 08, 2026 at a share price of $4.5. Whereas If you bought $1000 worth of Outset Medical, Inc. (OM) shares 5 years ago, it would be worth $5.55 as of February 08, 2026 at a share price of $4.5.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned
GlobeNewswire Inc.
Jan 27, 2026 2:00 PM GMT
Tablo becomes first dialysis system to clear FDA’s most rigorous cybersecurity standardsSAN JOSE, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to
Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026
GlobeNewswire Inc.
Jan 26, 2026 9:05 PM GMT
SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will rel
Outset Medical Reports Unaudited Fourth Quarter and 2025 Results
GlobeNewswire Inc.
Jan 12, 2026 1:30 PM GMT
Appoints Medical Technology Veteran Karen N. Prange to Board of DirectorsSAN JOSE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and co